Literature DB >> 22954895

Mouse models of Parkinson's disease associated with mitochondrial dysfunction.

Alicia M Pickrell1, Milena Pinto, Carlos T Moraes.   

Abstract

Despite years of intensive research, the understanding of Parkinson's disease (PD) is still rudimentary. Genetic causes of rare familial cases have offered venues of investigation, and interestingly, have strengthened the case for a mitochondrial dysfunction in the pathogenesis of PD. Mouse models, where these and other mitochondrial-related genes are affected are helping not only in understanding PD, but also in providing a powerful tool to test therapeutics. In this review, we will discuss the different characteristics of these mouse models. This article is part of a Special Issue entitled 'Mitochondrial function and dysfunction in neurodegeneration'.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22954895      PMCID: PMC3997253          DOI: 10.1016/j.mcn.2012.08.002

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  108 in total

1.  PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility.

Authors:  Xinnan Wang; Dominic Winter; Ghazaleh Ashrafi; Julia Schlehe; Yao Liang Wong; Dennis Selkoe; Sarah Rice; Judith Steen; Matthew J LaVoie; Thomas L Schwarz
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease.

Authors:  Alicia M Pickrell; Milena Pinto; Aline Hida; Carlos T Moraes
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

3.  Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.

Authors:  Giuseppa Mudò; Johanna Mäkelä; Valentina Di Liberto; Timofey V Tselykh; Melania Olivieri; Petteri Piepponen; Ove Eriksson; Annika Mälkiä; Alessandra Bonomo; Minna Kairisalo; Jose A Aguirre; Laura Korhonen; Natale Belluardo; Dan Lindholm
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

4.  Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

Authors:  Raymond H Kim; Patrice D Smith; Hossein Aleyasin; Shawn Hayley; Matthew P Mount; Scott Pownall; Andrew Wakeham; Annick J You-Ten; Suneil K Kalia; Patrick Horne; David Westaway; Andres M Lozano; Hymie Anisman; David S Park; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-22       Impact factor: 11.205

5.  Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1.

Authors:  Xian Lin; Loukia Parisiadou; Carmelo Sgobio; Guoxiang Liu; Jia Yu; Lixin Sun; Hoon Shim; Xing-Long Gu; Jing Luo; Cai-Xia Long; Jinhui Ding; Yolanda Mateo; Patricia H Sullivan; Ling-Gang Wu; David S Goldstein; David Lovinger; Huaibin Cai
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

6.  LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.

Authors:  Xinglong Wang; Michael H Yan; Hisashi Fujioka; Jun Liu; Amy Wilson-Delfosse; Shu G Chen; George Perry; Gemma Casadesus; Xiongwei Zhu
Journal:  Hum Mol Genet       Date:  2012-01-06       Impact factor: 6.150

7.  Altered dopamine metabolism and increased vulnerability to MPTP in mice with partial deficiency of mitochondrial complex I in dopamine neurons.

Authors:  Fredrik H Sterky; Alexander F Hoffman; Dusanka Milenkovic; Betty Bao; Arianna Paganelli; Daniel Edgar; Rolf Wibom; Carl R Lupica; Lars Olson; Nils-Göran Larsson
Journal:  Hum Mol Genet       Date:  2011-11-16       Impact factor: 6.150

8.  Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions.

Authors:  Matthias Elstner; Sarina K Müller; Lars Leidolt; Christoph Laub; Lena Krieg; Falk Schlaudraff; Birgit Liss; Chris Morris; Douglass M Turnbull; Eliezer Masliah; Holger Prokisch; Thomas Klopstock; Andreas Bender
Journal:  Mol Brain       Date:  2011-12-21       Impact factor: 4.041

9.  Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria.

Authors:  Song Liu; Tomoyo Sawada; Seongsoo Lee; Wendou Yu; George Silverio; Philomena Alapatt; Ivan Millan; Alice Shen; William Saxton; Tomoko Kanao; Ryosuke Takahashi; Nobutaka Hattori; Yuzuru Imai; Bingwei Lu
Journal:  PLoS Genet       Date:  2012-03-01       Impact factor: 5.917

10.  Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function.

Authors:  C Ciron; S Lengacher; J Dusonchet; P Aebischer; B L Schneider
Journal:  Hum Mol Genet       Date:  2012-01-12       Impact factor: 6.150

View more
  8 in total

1.  Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.

Authors:  Alicia M Pickrell; Chiu-Hui Huang; Scott R Kennedy; Alban Ordureau; Dionisia P Sideris; Jake G Hoekstra; J Wade Harper; Richard J Youle
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

2.  Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid β-oxidation, supporting acetyl-coenzyme A levels.

Authors:  Andrew J Worth; Sankha S Basu; Nathaniel W Snyder; Clementina Mesaros; Ian A Blair
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

Review 3.  Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?

Authors:  Grzegorz Kreiner
Journal:  Front Cell Neurosci       Date:  2015-03-06       Impact factor: 5.505

Review 4.  Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review.

Authors:  Alexander Hawlitschka; Andreas Wree
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

Review 5.  Mitochondrial DNA damage induced autophagy, cell death, and disease.

Authors:  Bennett Van Houten; Senyene E Hunter; Joel N Meyer
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

6.  Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation.

Authors:  Milena Pinto; Nadee Nissanka; Susana Peralta; Roberta Brambilla; Francisca Diaz; Carlos T Moraes
Journal:  Mol Neurodegener       Date:  2016-04-02       Impact factor: 14.195

Review 7.  Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.

Authors:  Daniela Maria Vogt Weisenhorn; Florian Giesert; Wolfgang Wurst
Journal:  J Neurochem       Date:  2016-06-27       Impact factor: 5.372

8.  Unilateral Botulinum Neurotoxin-A Injection into the Striatum of C57BL/6 Mice Leads to a Different Motor Behavior Compared with Rats.

Authors:  Veronica Antipova; Andreas Wree; Carsten Holzmann; Teresa Mann; Nicola Palomero-Gallagher; Karl Zilles; Oliver Schmitt; Alexander Hawlitschka
Journal:  Toxins (Basel)       Date:  2018-07-17       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.